Column Group’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69K | Hold |
46
| – | – | ﹤0.01% | 5 |
|
|
2025
Q1 | $1.63K | Hold |
46
| – | – | ﹤0.01% | 5 |
|
|
2024
Q4 | $2.09K | Hold |
46
| – | – | ﹤0.01% | 5 |
|
|
2024
Q3 | $2.09K | Hold |
46
| – | – | ﹤0.01% | 6 |
|
|
2024
Q2 | $1.79K | Hold |
46
| – | – | ﹤0.01% | 6 |
|
|
2024
Q1 | $1.48K | Hold |
46
| – | – | ﹤0.01% | 7 |
|
|
2023
Q4 | $1.32K | Sell |
46
-1,230,595
| -100% | -$35.3M | ﹤0.01% | 6 |
|
|
2023
Q3 | $34.1M | Sell |
1,230,641
-1,346,579
| -52% | -$37.3M | 22.62% | 2 |
|
|
2023
Q2 | $68.9M | Sell |
2,577,220
-2,000,620
| -44% | -$53.5M | 26.76% | 1 |
|
|
2023
Q1 | $99.2M | Hold |
4,577,840
| – | – | 35.85% | 1 |
|
|
2022
Q4 | $109M | Hold |
4,577,840
| – | – | 36.3% | 1 |
|
|
2022
Q3 | $90.3M | Buy |
4,577,840
+182,790
| +4% | +$3.6M | 19.98% | 2 |
|
|
2022
Q2 | $85.7M | Buy |
4,395,050
+1,047,805
| +31% | +$20.4M | 18.23% | 2 |
|
|
2022
Q1 | $85.4M | Hold |
3,347,245
| – | – | 15.83% | 3 |
|
|
2021
Q4 | $84.3M | Hold |
3,347,245
| – | – | 11.46% | 3 |
|
|
2021
Q3 | $92.1M | Hold |
3,347,245
| – | – | 10.47% | 4 |
|
|
2021
Q2 | $106M | Sell |
3,347,245
-233,007
| -7% | -$7.4M | 15.04% | 3 |
|
|
2021
Q1 | $164M | Hold |
3,580,252
| – | – | 15.74% | 3 |
|
|
2020
Q4 | $142M | Buy |
+3,580,252
| New | +$142M | 12.86% | 4 |
|